← All candidates
13 insider filings on record.
19 filings on record.
PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC.
NasdaqGS · Healthcare · $414.96M
$1.34
+0.00% today
13 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 7 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$414.96M
Float
304.0M
98% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
2.6
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
8 more transactions on Pro →Context
Wall St
$2.46 avg target
+83.5% vs today · 6 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q1 '26−$0.12 act+$0.01
Q4 '25−$0.12 act+$0.01
Q3 '25−$0.12 act+$0.02
Q2 '25−$0.13 act+$0.04
Coverage
Pacific Biosciences of California (PACB) Laps the Stock Market: Here's WhyZacks · 07-28Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader MarketZacks · 07-20Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should KnowZacks · 07-13Here's Why You Should Add PacBio Stock to Your Portfolio NowZacks · 07-07
The file stays open
19 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice